WHO Names 17 Pathogens as Top Priorities for Global Vaccine Development
A new World Health Organization (WHO) study published in eBioMedicine last week highlights 17 viral and bacterial pathogens that are major sources of endemic disease around the world and that WHO officials believe should be urgently prioritized for vaccine development. The study marks the WHO’s first global effort to systematically prioritize endemic pathogens with epidemic […]
Man Suffers Painful Facial Nerve Damage After Pfizer’s mRNA COVID-19 Booster Shot
A 54-year-old man from the Omagh, Northern Ireland suffered a severe adverse reaction just days after receiving the Pfizer/BioNTech’s Comirnaty mRNA (messenger ribonucleic acid) COVID-19 booster shot in December 2021. Larry Lowe, a former college lecturer, musician and runner, said he developed numbness on the right side of his face and began to experience severe […]
Moderna Offered Children £1,500 to Enroll in COVID Booster Shot Trial
The Prescription Medicines Code of Practice Authority (PMCPA), an organization responsible for overseeing the marketing practices of pharmaceutical companies in the United Kingdom, criticized Moderna, Inc. for sending an unauthorized WhatsApp message that proposed a payment of £1,500 (about $2,000) to children for participating in a clinical trial for its COVID-19 booster shot.1 Complaint Filed […]
Food Allergy Diagnoses in England Have Doubled
Results from a new study published in The Lancet earlier this month indicate that there are more children and adults in England suffering with food allergies. The study, which was conducted by researchers at Imperial College in London, showed that the incidence of food allergies among adults and children doubled between 2008 and 2018.1 The […]
Reports of Eye Disorders Spike After COVID Shots
In 2021, the World Health Organization’s (WHO) European drug monitoring system known as Vigibase, maintained by the Uppsala Monitoring Centre (UMC) in Sweden, received 19,916 reports of eye disorders following administration of COVID-19 shots. Vigibase had never recorded such a big spike in eye disorders until these biologics were introduced into the European market.1 Eye […]
Novel Breast Cancer Vaccine Technology Receives Japanese Patent
Anixa Biosciences, Inc. of San Jose, California announced on July 17, 2024, that its collaborator, the Cleveland Clinic, has received a “Decision to Grant” notice from the Japan Patent Office (JPO) for the patent application titled “Vaccine Adjuvants and Formulations” for its novel breast cancer vaccine technology. The company is two decades into developing a […]